Introduction
Gangliogliomas (GG) represent the most frequent tumor entity in young patients undergoing surgery for drug-refractory epilepsy. 1 GG commonly correspond to WHO grade I tumors and are histopathologically characterized by dysplastic neurons and neoplastic astroglial cells. Typically, contrast enhancement is present on magnetic resonance imaging (MRI) pointing to bloodbrain barrier (BBB) dysfunction. Mechanisms underlying the high epileptogenicity of GG are still enigmatic. Factors such as impaired neurochemical homeostasis, genetic and peritumoural changes have been suggested to underlie increased neuronal excitability. 2, 3 Recent data emphasized a contribution of BBB leakage to the progression of epilepsy, [4] [5] [6] with astroglial albumin uptake as a key pathogenic factor. 4, 7, 8 Frequent deposits of hemosiderin indicate an impairment of the BBB in this tumor entity. Accordingly, we analyzed hemosiderin deposits and astroglial albumin accumulation in tumor and adjacent brain tissue of GG and in several 'control' pathologies.
Materials and methods

Patients and surgical specimens
Biopsy specimens were obtained from patients who underwent neurosurgery at the University of Bonn using controls as follows. Dysembryoplastic neuroepithelial tumors (DNT; WHO grade I) represent a further highly epilepsy-associated glioneuronal tumor entity. Diffuse astrocytomas (DA; WHO grade II) Purpose: Low-grade neuroepithelial tumors are frequent neuropathological findings in patients with pharmacoresistant epilepsies. Little is known regarding epileptogenic mechanisms in this group of neoplasms with gangliogliomas (GG) as the most common entity. Presence of hemosiderin deposits in GG points to impairment of the blood-brain barrier (BBB). Therefore, we hypothesized a potential role of BBB dysfunction and astrocytic albumin uptake as potential epileptogenic factor in GG. Methods: Prussian blue staining and fluorescent double-immunohistochemistry with antibodies against albumin, GFAP, CD34 and GLUT-1 were used to analyze hemosiderin deposits and astroglial albumin accumulation in tumor and adjacent pre-existing brain tissue of GG (n = 10) and several control groups, i.e. dysembryoplastic neuroepithelial tumors (DNT; n = 5), focal cortical dysplasia with balloon cells (FCD IIb; n = 10), astrocytomas WHO grade II (n = 5) and clear renal cell carcinoma brain metastases (RCCM, n = 6). Results: Our results revealed strong hemosiderin deposits in GG. Intriguingly, we noted substantial albumin uptake exclusively in neoplastic glial cell components of GG and DNT, whereas no significant albumin was present in perilesional reactive astrocytes. Strikingly, we did not observe substantial albumin uptake in further controls. Conclusion: Glial albumin uptake was restricted to long-term epilepsy associated, vasculaturecontaining tumors. Intratumoural BBB dysfunction in concert with subsequent accumulation of albumin by neoplastic glial cell elements represent a new putatively epileptogenic mechanism for longterm epilepsy-associated tumors.
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largely share morphological features of the astroglial component in GG but lack contrast enhancement and the strong association with drug-refractory epilepsy. Focal cortical dysplasias with balloon cells (FCD IIb) represent non-neoplastic epilepsyassociated lesions without a vascular component. 9 Finally, clear renal cell carcinoma brain metastases (RCCM) often encounter neuropathological hemosiderin deposits and contrast enhancement on MRI. Here, seizures are rather acute than chronic (GG: n = 10; DNT: n = 5; FCD IIb: n = 10; DA: n = 5; RCCM: n = 6). All procedures were carried out in accordance with the declaration of Helsinki. The clinical parameters of the patients are summarized in Table 1A .
Tissue processing, immunohistochemistry, doubleimmunofluorescence and image analysis
These procedures were performed as described before, 10 
Results
Lesional regions of GG were mostly positive for hemosiderin with a variation from none (n = 2) over few (n = 4) to intermediate (n = 4) deposits. In perilesional regions few (n = 1) to none (n = 9) hemosiderin amount were detected (Tables 1A and 1B) . We observed astrocytic deposits of albumin in all GG varying from abundant (n = 1) over intermediate (n = 7) to few (n = 2; Fig. 1A ). Linear regression analysis showed no correlation between albumin accumulation and duration of epilepsy (R 2 = 0.019; p = 0.7). In perilesional regions we found less (n = 1) to none (n = 9) albumin uptake (Fig. 1B) . Glucose transporter-1 (GLUT-1) is highly colocalized with CD-34 in vascular endothelial cells, but lacks differences in lesional versus perilesional tissue of GG or in comparison to other entities (Fig. A4) . In FCD IIb, hemosiderin deposits were exceptional, both in lesional (n = 1) and perilesional (n = 1) tissue. GFAP/albumin double-immunohistochemistry showed no substantial albumin uptake in the lesional and perilesional areas (n = 7, Fig. 1C ). Only in three cases (n = 3), we observed few albumin in astrocytes. CD34/ albumin co-stainings confirmed mainly intravascular localization of albumin in FCD IIb (Fig. A5A) . In DA, neither hemosiderin nor astrocytic albumin deposits were present in lesional or perilesional regions (n = 5; Figs. 1D and A5B) .
Intralesional hemosiderin deposits varied in RCCM between few (n = 3), intermediate (n = 2) and abundant (n = 1). In perilesional tissue none (n = 3), few (n = 2) or abundant (n = 1) accumulation of hemosiderin was present. Analysis of GFAP/ albumin co-staining revealed none (n = 4) or few (n = 2) astrocytic albumin uptake in adjacent CNS (Tables 1A and 1B, Figs. 1E and  A5C) . Obviously, no relevant number of intratumoural asctrocytes is present in RCCMs.
In three DNT samples intralesional hemosiderin deposits were observed. Relevant albumin accumulation in perivascular glial elements were present in all cases, but mostly low (Fig. A3) . Perilesional astrocytes showed no definite albumin uptake. Neither DNT nor GG were associated with perilesional focal cortical dysplasia.
Discussion
Although composed of highly similar cellular components, the epileptogenicity of individual low grade brain neoplasms is strikingly different. In contrast to what may be anticipated due to the diffusely infiltrating growth pattern of DAs, these tumors are not highly epileptogenic. In fact, circumscribed primary brain tumors, particularly GG are most frequently associated with chronic epilepsy. This has been primarily claimed to rely on the presence of dysmorphic neurons within the tumor resulting in imbalances of neurotransmitters, receptors and ion channels. 3 Although these factors may indeed contribute to epileptogenicity, some aspects argue for additional relevant factors. Firstly, removal of the tumor does not always result in seizure relief. Secondly, also pure vascular lesions such as cavernomas are highly epileptogenic. Only recently BBBdysfunction and albumin storage by adjacent reactive astroglia have been described in human epileptic tissue and claimed as pathogenetic factors. 10 Here, we observed uptake of albumin by intratumoural astroglial cells in GG that from their cellular shape and distribution pattern have to be categorized as neoplastic astroglia. As summarized in Table 1B neither BBB impairment (indicated by hemosiderin deposits and contrast enhancement), nor a glial tumor component nor chronic epilepsy as single parameter were paralleled by astroglial albumin accumulation. However, in GG and DNT, which harbor all three features, glial albumin accumulation was also detectable. Do our data argue for albumin uptake by astroglial GG components as an epileptogenic mechanism? Our control experiments revealed that low grade astroglial tumors, i.e. DA (WHO grade II), not associated with chronic seizures, do not show albumin uptake by tumor cells. This result may argue for albumin uptake in GG astroglia to represent an epilepsyassociated mechanism. However, the lack of albumin uptake in FCD IIb glial elements suggests that astroglial albumin uptake is not necessarily associated with epileptogenesis. Furthermore, the absence of albumin accumulation in astrocytes within FCD IIb strongly argues against albumin uptake by GG astroglia as an unspecific consequence of epileptic seizures.
In RCCM, as an example of fast growing neoplasms, that frequently demonstrate hemosiderin deposits as neuropathological correlate of BBB dysfunction, we did not observe significant uptake of albumin by adjacent reactive astroglia. However, patients with RCCM included in the present study showed acute sporadic epileptic seizures but did not suffer from chronic epilepsy. In rats the application of albumin on the surface of the neocortex has been shown to generate an epileptic focus. 4, 11 Furthermore, artificial opening of BBB by mannitol in chronic epileptic rats results in increased seizure frequency. 5 Regarding a potential molecular mechanism of BBB leakage and subsequent epileptogenesis or aggravation of epilepsy, recent studies indicated that albumin underlies the transformation of astrocytes from a ''resting'' to a ''reactive'' state through transforming growth factor b (TGF-b) signaling. 4, 8 Recent data on albumin uptake by reactive astroglia adjacent to malformed blood vessels argues for a phenomenon associated with long term chronic epilepsy. 10 In contrast to data from experimental animal models, where albumin leakage is based on a transient functional BBB disruption, in human vascular malformations 10 and GG, blood vessels are of aberrant architecture. 12 These considerations may argue for a structural BBB dysfunction in such human chronic epilepsy associated lesions. However, we were not able to resolve the molecular mechanisms that may cause BBB dysfunction in GG. We excluded reduced levels of GLUT-1 in GG endothelia as potential mechanism (Fig. A4) . Others, we will address in the future.
Finally, our results have certain clinical aspects. Whereas gross total resection of GG may not always be indicated under neurooncologic perspectives, albumin-containing astroglia as potential epileptogenic cell population of GG may be neurosurgically be minimized based on careful MRI-and EEG based mapping of the seizure generating area prior to epilepsy-surgery. In future attempts, anti-angiogenic treatment may provide epilepsy-therapy perspectives in patients with GG in functional locations.
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